News & insights
Roche
Articles from Apotek Analytics.
-

US loses measles elimination status while Isomorphic raises record $5bn
Global health authorities said the United States has lost its measles elimination status after several states faced their worst outbreaks in nearly three decades, and the CDC and partners set out plans to stop the outbreaks and restore it.
-

Pfizer, Roche and AstraZeneca lead a week of drug discovery deals
Pfizer, Roche and AstraZeneca each struck discovery deals reported at $500m or more, as regulators in the UK, US and Europe signalled changes in how they weigh evidence.
-

FDA approves AbbVie’s first-in-class Parkinson’s pill as pharma deal-making accelerates
The FDA approved AbbVie’s tavapadon, branded Juvmo, for adults with Parkinson’s disease, as deal-making dominated the rest of the week.